Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

December 1, 2025

Conditions

Pruritus Caused by Drug

Interventions

DRUG

Ondansetron 8mg

administration of an IV solution of 8mg ondansetron (4ml)

Trial Locations (1)

RECRUITING

Detroit Medical Center- Hutzel Women's Hospital, Detroit

All Listed Sponsors

lead

Wayne State University

OTHER